或在周一！辉瑞疫苗将在美国全面获批

华尔街见闻2021-08-22

不仅能为更多的人提供保护，全面获批也可能是辉瑞疫苗的一大里程碑。据《纽约时报》援引消息人士的话报道称，美国食品和药物管理局(FDA)可能于周一全面批准辉瑞公司的新冠疫苗。随着文书工作和与辉瑞的谈判继续进行，最终审查结果可能会超过这一日期，此举将使辉瑞的疫苗成为首个从紧急使用授权到完全获得FDA批准的新冠疫苗。 8月8日，白宫首席医疗顾问安东尼·福奇(Anthony Fauci)博士对美联社表示...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Sallysee
2021-08-22
Sallysee
[開心]
thomaschai
2021-08-22
thomaschai
Jsjsj
Jessie8590
2021-08-22
Jessie8590
[強]

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2161274943?lang=en_US&edition=fundamental","thumbnail":"https://static.tigerbbs.com/6e474d690ea02c536f0fd4c03fc3ddef","is_english":false,"pubTime":"2021-08-22 08:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2161274943","market":"us","top_or_hot":-1,"title":"或在周一！辉瑞疫苗将在美国全面获批","media":"华尔街见闻","content":"<div>\n<p>不仅能为更多的人提供保护，全面获批也可能是辉瑞疫苗的一大里程碑。\n据《纽约时报》援引消息人士的话报道称，美国食品和药物管理局(FDA)可能于周一全面批准辉瑞公司的新冠疫苗。\n随着文书工作和与辉瑞的谈判继续进行，最终审查结果可能会超过这一日期，此举将使辉瑞的疫苗成为首个从紧急使用授权到完全获得FDA批准的新冠疫苗。\n8月8日，白宫首席医疗顾问安东尼·福奇(Anthony Fauci)博士对美联社表示...</p>\n\n<a href=\"https://wallstreetcn.com/articles/3638520\">Source Link</a>\n\n</div>\n","source":"wallstreetcn_api","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>或在周一！辉瑞疫苗将在美国全面获批</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n或在周一！辉瑞疫苗将在美国全面获批\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-22 08:40 北京时间&nbsp;&nbsp;&nbsp;<a href=https://wallstreetcn.com/articles/3638520><strong>华尔街见闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>不仅能为更多的人提供保护，全面获批也可能是辉瑞疫苗的一大里程碑。\n据《纽约时报》援引消息人士的话报道称，美国食品和药物管理局(FDA)可能于周一全面批准辉瑞公司的新冠疫苗。\n随着文书工作和与辉瑞的谈判继续进行，最终审查结果可能会超过这一日期，此举将使辉瑞的疫苗成为首个从紧急使用授权到完全获得FDA批准的新冠疫苗。\n8月8日，白宫首席医疗顾问安东尼·福奇(Anthony Fauci)博士对美联社表示...</p>\n\n<a href=\"https://wallstreetcn.com/articles/3638520\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://wallstreetcn.com/articles/3638520","article_id":"2161274943","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/6e474d690ea02c536f0fd4c03fc3ddef"],"rights":{"source":"wallstreetcn_api","url":"https://wallstreetcn.com/articles/3638520","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2161274943","pubTimestamp":1629592848,"columns":[],"sourceInfo":{"source_id":"wallstreetcn_api","name":"华尔街见闻"},"weMediaInfo":null,"summary":"不仅能为更多的人提供保护，全面获批也可能是辉瑞疫苗的一大里程碑。\n据《纽约时报》援引消息人士的话报道称，美国食品和药物管理局(FDA)可能于周一全面批准辉瑞公司的新冠疫苗。\n随着文书工作和与辉瑞的谈判","collect":0,"end_time":0,"defaultTopTitle":"wallstreetcn.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{},"translate_title":"Or on Monday! Pfizer vaccine will be fully approved in the United States","themeId":null,"isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/c4a2a96ca94de2a928cbc223d77e8f21","symbols_score_info":{},"content_text":"不仅能为更多的人提供保护，全面获批也可能是辉瑞疫苗的一大里程碑。\n据《纽约时报》援引消息人士的话报道称，美国食品和药物管理局(FDA)可能于周一全面批准辉瑞公司的新冠疫苗。\n随着文书工作和与辉瑞的谈判继续进行，最终审查结果可能会超过这一日期，此举将使辉瑞的疫苗成为首个从紧急使用授权到完全获得FDA批准的新冠疫苗。\n8月8日，白宫首席医疗顾问安东尼·福奇(Anthony Fauci)博士对美联社表示，他希望疫苗将在8月之内获得全面批准，这将使更多公司和学校强制要求人们接种疫苗。\n随着最近几周美国各地新冠病例的激增，美国各大公司对员工接种疫苗的相关规定也越来越严格。一些公司称，会将FDA的全面批准作为其决策过程的一部分。\n截至周五，美国疾病控制与预防中心（CDC）的数据显示，辉瑞的疫苗已经在全国范围内接种了超过2.03亿剂，使美国超过9100万人得到有效保护。\n辉瑞和BioNTech公司在去年12月获得FDA的紧急使用授权后，于今年5月开始申请疫苗的生物制药许可证。\n据CNBC此前报道，获得欧盟授权的制药商被禁止推广他们的疫苗。\n但如果获得正式授权，辉瑞和BioNTech的疫苗在疫情结束后仍将在市场上销售，而且能够直接向消费者宣传其疫苗。\n在8月16日，两家公司宣布，在向FDA提交临床试验数据后，他们开始了对完全接种者提供加强针的批准程序。\n另外，CDC、白宫和FDA等机构的高级卫生官员周三在一份声明中称，mRNA疫苗的有效性会随着时间的推移而下降，尤其是对那些免疫系统受损的人。\n他们表示，美国将于9月份开始向公众分发加强型的疫苗。","kind":"highlight","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[{"id":832671590,"gmtCreate":1629629811210,"gmtModify":1676530082526,"author":{"id":"4089440955592960","authorId":"4089440955592960","name":"Sallysee","avatar":"https://static.tigerbbs.com/5e6bf86ee526d9b6ea980a576c1d368f","vip":1,"crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"4089440955592960","idStr":"4089440955592960"},"htmlText":"[開心]&nbsp;","listText":"[開心]&nbsp;","text":"[開心]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/832671590","repostId":2161274943,"repostType":2,"repost":{"id":"2161274943","kind":"highlight","pubTimestamp":1629592848,"share":"https://ttm.financial/m/news/2161274943?lang=en_US&edition=fundamental","pubTime":"2021-08-22 08:40","market":"us","language":"zh","title":"Or on Monday! Pfizer vaccine to be fully approved in the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2161274943","media":"华尔街见闻","summary":"不仅能为更多的人提供保护，全面获批也可能是辉瑞疫苗的一大里程碑。\n据《纽约时报》援引消息人士的话报道称，美国食品和药物管理局(FDA)可能于周一全面批准辉瑞公司的新冠疫苗。\n随着文书工作和与辉瑞的谈判","content":"<p>Not only can it provide protection for more people, but full approval may also be<a href=\"https://laohu8.com/S/PFE\">Pfizer</a>A big milestone for vaccines.</p><p>According to<a href=\"https://laohu8.com/S/NYT\">The New York Times</a>The U.S. Food and Drug Administration (FDA) could fully approve Pfizer's COVID-19 vaccine on Monday, \"reported, citing sources.</p><p>The final review outcome could exceed that date as paperwork and negotiations with Pfizer continue, a move that would make Pfizer's vaccine the first COVID-19 vaccine to go from emergency use authorization to full FDA approval.</p><p>On Aug. 8, Dr. Anthony Fauci, the White House's chief medical adviser, told The Associated Press that he hopes the vaccine will be fully approved within August, which will make more companies and schools mandatory for people to get vaccinated.</p><p>With the surge of new crown cases across the United States in recent weeks, major U.S. companies have become increasingly stringent on vaccinating employees. Some companies say they will use full FDA approval as part of their decision-making process.</p><p>As of Friday, data from the Centers for Disease Control and Prevention (CDC) showed that<b>More than 203 million doses of Pfizer's vaccine have been administered nationwide, effectively protecting more than 91 million people in the United States.</b></p><p>Pfizer and BioNTech began applying for biopharmaceutical licenses for vaccines in May this year after receiving emergency use authorization from the FDA in December last year.</p><p>As previously reported by CNBC, drugmakers authorized by the European Union were banned from promoting their vaccines.</p><p>But if duly authorized,<b>Pfizer and BioNTech's vaccines will remain on the market after the epidemic is over, and they will be able to promote their vaccines directly to consumers.</b></p><p>On August 16, the two companies announced that after submitting clinical trial data to the FDA, they had begun the approval process to provide booster shots to fully vaccinated people.</p><p>Separately, senior health officials from agencies such as the CDC, the White House and the FDA said in a statement Wednesday that the effectiveness of mRNA vaccines will decline over time, especially for those with impaired immune systems.</p><p>They said that the United States will begin distributing the booster vaccine to the public in September.</p>","source":"wallstreetcn_api","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Or on Monday! Pfizer vaccine to be fully approved in the United States</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOr on Monday! Pfizer vaccine to be fully approved in the United States\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">华尔街见闻</strong><span class=\"h-time small\">2021-08-22 08:40</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Not only can it provide protection for more people, but full approval may also be<a href=\"https://laohu8.com/S/PFE\">Pfizer</a>A big milestone for vaccines.</p><p>According to<a href=\"https://laohu8.com/S/NYT\">The New York Times</a>The U.S. Food and Drug Administration (FDA) could fully approve Pfizer's COVID-19 vaccine on Monday, \"reported, citing sources.</p><p>The final review outcome could exceed that date as paperwork and negotiations with Pfizer continue, a move that would make Pfizer's vaccine the first COVID-19 vaccine to go from emergency use authorization to full FDA approval.</p><p>On Aug. 8, Dr. Anthony Fauci, the White House's chief medical adviser, told The Associated Press that he hopes the vaccine will be fully approved within August, which will make more companies and schools mandatory for people to get vaccinated.</p><p>With the surge of new crown cases across the United States in recent weeks, major U.S. companies have become increasingly stringent on vaccinating employees. Some companies say they will use full FDA approval as part of their decision-making process.</p><p>As of Friday, data from the Centers for Disease Control and Prevention (CDC) showed that<b>More than 203 million doses of Pfizer's vaccine have been administered nationwide, effectively protecting more than 91 million people in the United States.</b></p><p>Pfizer and BioNTech began applying for biopharmaceutical licenses for vaccines in May this year after receiving emergency use authorization from the FDA in December last year.</p><p>As previously reported by CNBC, drugmakers authorized by the European Union were banned from promoting their vaccines.</p><p>But if duly authorized,<b>Pfizer and BioNTech's vaccines will remain on the market after the epidemic is over, and they will be able to promote their vaccines directly to consumers.</b></p><p>On August 16, the two companies announced that after submitting clinical trial data to the FDA, they had begun the approval process to provide booster shots to fully vaccinated people.</p><p>Separately, senior health officials from agencies such as the CDC, the White House and the FDA said in a statement Wednesday that the effectiveness of mRNA vaccines will decline over time, especially for those with impaired immune systems.</p><p>They said that the United States will begin distributing the booster vaccine to the public in September.</p>\n<div class=\"bt-text\">\n\n\n<p> source：<a href=\"https://wallstreetcn.com/articles/3638520\">华尔街见闻</a></p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/6e474d690ea02c536f0fd4c03fc3ddef","relate_stocks":{},"source_url":"https://wallstreetcn.com/articles/3638520","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2161274943","content_text":"不仅能为更多的人提供保护，全面获批也可能是辉瑞疫苗的一大里程碑。\n据《纽约时报》援引消息人士的话报道称，美国食品和药物管理局(FDA)可能于周一全面批准辉瑞公司的新冠疫苗。\n随着文书工作和与辉瑞的谈判继续进行，最终审查结果可能会超过这一日期，此举将使辉瑞的疫苗成为首个从紧急使用授权到完全获得FDA批准的新冠疫苗。\n8月8日，白宫首席医疗顾问安东尼·福奇(Anthony Fauci)博士对美联社表示，他希望疫苗将在8月之内获得全面批准，这将使更多公司和学校强制要求人们接种疫苗。\n随着最近几周美国各地新冠病例的激增，美国各大公司对员工接种疫苗的相关规定也越来越严格。一些公司称，会将FDA的全面批准作为其决策过程的一部分。\n截至周五，美国疾病控制与预防中心（CDC）的数据显示，辉瑞的疫苗已经在全国范围内接种了超过2.03亿剂，使美国超过9100万人得到有效保护。\n辉瑞和BioNTech公司在去年12月获得FDA的紧急使用授权后，于今年5月开始申请疫苗的生物制药许可证。\n据CNBC此前报道，获得欧盟授权的制药商被禁止推广他们的疫苗。\n但如果获得正式授权，辉瑞和BioNTech的疫苗在疫情结束后仍将在市场上销售，而且能够直接向消费者宣传其疫苗。\n在8月16日，两家公司宣布，在向FDA提交临床试验数据后，他们开始了对完全接种者提供加强针的批准程序。\n另外，CDC、白宫和FDA等机构的高级卫生官员周三在一份声明中称，mRNA疫苗的有效性会随着时间的推移而下降，尤其是对那些免疫系统受损的人。\n他们表示，美国将于9月份开始向公众分发加强型的疫苗。","news_type":1,"symbols_score_info":{}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":832153466,"gmtCreate":1629600244255,"gmtModify":1676530076827,"author":{"id":"4090730840029950","authorId":"4090730840029950","name":"thomaschai","avatar":"https://static.tigerbbs.com/60d0ea90d448581d311ba0fca8614ef4","vip":1,"crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"4090730840029950","idStr":"4090730840029950"},"htmlText":"Jsjsj","listText":"Jsjsj","text":"Jsjsj","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/832153466","repostId":2161274943,"repostType":2,"repost":{"id":"2161274943","kind":"highlight","pubTimestamp":1629592848,"share":"https://ttm.financial/m/news/2161274943?lang=en_US&edition=fundamental","pubTime":"2021-08-22 08:40","market":"us","language":"zh","title":"Or on Monday! Pfizer vaccine to be fully approved in the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2161274943","media":"华尔街见闻","summary":"不仅能为更多的人提供保护，全面获批也可能是辉瑞疫苗的一大里程碑。\n据《纽约时报》援引消息人士的话报道称，美国食品和药物管理局(FDA)可能于周一全面批准辉瑞公司的新冠疫苗。\n随着文书工作和与辉瑞的谈判","content":"<p>Not only can it provide protection for more people, but full approval may also be<a href=\"https://laohu8.com/S/PFE\">Pfizer</a>A big milestone for vaccines.</p><p>According to<a href=\"https://laohu8.com/S/NYT\">The New York Times</a>The U.S. Food and Drug Administration (FDA) could fully approve Pfizer's COVID-19 vaccine on Monday, \"reported, citing sources.</p><p>The final review outcome could exceed that date as paperwork and negotiations with Pfizer continue, a move that would make Pfizer's vaccine the first COVID-19 vaccine to go from emergency use authorization to full FDA approval.</p><p>On Aug. 8, Dr. Anthony Fauci, the White House's chief medical adviser, told The Associated Press that he hopes the vaccine will be fully approved within August, which will make more companies and schools mandatory for people to get vaccinated.</p><p>With the surge of new crown cases across the United States in recent weeks, major U.S. companies have become increasingly stringent on vaccinating employees. Some companies say they will use full FDA approval as part of their decision-making process.</p><p>As of Friday, data from the Centers for Disease Control and Prevention (CDC) showed that<b>More than 203 million doses of Pfizer's vaccine have been administered nationwide, effectively protecting more than 91 million people in the United States.</b></p><p>Pfizer and BioNTech began applying for biopharmaceutical licenses for vaccines in May this year after receiving emergency use authorization from the FDA in December last year.</p><p>As previously reported by CNBC, drugmakers authorized by the European Union were banned from promoting their vaccines.</p><p>But if duly authorized,<b>Pfizer and BioNTech's vaccines will remain on the market after the epidemic is over, and they will be able to promote their vaccines directly to consumers.</b></p><p>On August 16, the two companies announced that after submitting clinical trial data to the FDA, they had begun the approval process to provide booster shots to fully vaccinated people.</p><p>Separately, senior health officials from agencies such as the CDC, the White House and the FDA said in a statement Wednesday that the effectiveness of mRNA vaccines will decline over time, especially for those with impaired immune systems.</p><p>They said that the United States will begin distributing the booster vaccine to the public in September.</p>","source":"wallstreetcn_api","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Or on Monday! Pfizer vaccine to be fully approved in the United States</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOr on Monday! Pfizer vaccine to be fully approved in the United States\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">华尔街见闻</strong><span class=\"h-time small\">2021-08-22 08:40</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Not only can it provide protection for more people, but full approval may also be<a href=\"https://laohu8.com/S/PFE\">Pfizer</a>A big milestone for vaccines.</p><p>According to<a href=\"https://laohu8.com/S/NYT\">The New York Times</a>The U.S. Food and Drug Administration (FDA) could fully approve Pfizer's COVID-19 vaccine on Monday, \"reported, citing sources.</p><p>The final review outcome could exceed that date as paperwork and negotiations with Pfizer continue, a move that would make Pfizer's vaccine the first COVID-19 vaccine to go from emergency use authorization to full FDA approval.</p><p>On Aug. 8, Dr. Anthony Fauci, the White House's chief medical adviser, told The Associated Press that he hopes the vaccine will be fully approved within August, which will make more companies and schools mandatory for people to get vaccinated.</p><p>With the surge of new crown cases across the United States in recent weeks, major U.S. companies have become increasingly stringent on vaccinating employees. Some companies say they will use full FDA approval as part of their decision-making process.</p><p>As of Friday, data from the Centers for Disease Control and Prevention (CDC) showed that<b>More than 203 million doses of Pfizer's vaccine have been administered nationwide, effectively protecting more than 91 million people in the United States.</b></p><p>Pfizer and BioNTech began applying for biopharmaceutical licenses for vaccines in May this year after receiving emergency use authorization from the FDA in December last year.</p><p>As previously reported by CNBC, drugmakers authorized by the European Union were banned from promoting their vaccines.</p><p>But if duly authorized,<b>Pfizer and BioNTech's vaccines will remain on the market after the epidemic is over, and they will be able to promote their vaccines directly to consumers.</b></p><p>On August 16, the two companies announced that after submitting clinical trial data to the FDA, they had begun the approval process to provide booster shots to fully vaccinated people.</p><p>Separately, senior health officials from agencies such as the CDC, the White House and the FDA said in a statement Wednesday that the effectiveness of mRNA vaccines will decline over time, especially for those with impaired immune systems.</p><p>They said that the United States will begin distributing the booster vaccine to the public in September.</p>\n<div class=\"bt-text\">\n\n\n<p> source：<a href=\"https://wallstreetcn.com/articles/3638520\">华尔街见闻</a></p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/6e474d690ea02c536f0fd4c03fc3ddef","relate_stocks":{},"source_url":"https://wallstreetcn.com/articles/3638520","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2161274943","content_text":"不仅能为更多的人提供保护，全面获批也可能是辉瑞疫苗的一大里程碑。\n据《纽约时报》援引消息人士的话报道称，美国食品和药物管理局(FDA)可能于周一全面批准辉瑞公司的新冠疫苗。\n随着文书工作和与辉瑞的谈判继续进行，最终审查结果可能会超过这一日期，此举将使辉瑞的疫苗成为首个从紧急使用授权到完全获得FDA批准的新冠疫苗。\n8月8日，白宫首席医疗顾问安东尼·福奇(Anthony Fauci)博士对美联社表示，他希望疫苗将在8月之内获得全面批准，这将使更多公司和学校强制要求人们接种疫苗。\n随着最近几周美国各地新冠病例的激增，美国各大公司对员工接种疫苗的相关规定也越来越严格。一些公司称，会将FDA的全面批准作为其决策过程的一部分。\n截至周五，美国疾病控制与预防中心（CDC）的数据显示，辉瑞的疫苗已经在全国范围内接种了超过2.03亿剂，使美国超过9100万人得到有效保护。\n辉瑞和BioNTech公司在去年12月获得FDA的紧急使用授权后，于今年5月开始申请疫苗的生物制药许可证。\n据CNBC此前报道，获得欧盟授权的制药商被禁止推广他们的疫苗。\n但如果获得正式授权，辉瑞和BioNTech的疫苗在疫情结束后仍将在市场上销售，而且能够直接向消费者宣传其疫苗。\n在8月16日，两家公司宣布，在向FDA提交临床试验数据后，他们开始了对完全接种者提供加强针的批准程序。\n另外，CDC、白宫和FDA等机构的高级卫生官员周三在一份声明中称，mRNA疫苗的有效性会随着时间的推移而下降，尤其是对那些免疫系统受损的人。\n他们表示，美国将于9月份开始向公众分发加强型的疫苗。","news_type":1,"symbols_score_info":{}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":832329270,"gmtCreate":1629593052590,"gmtModify":1676530073883,"author":{"id":"3571194868777759","authorId":"3571194868777759","name":"Jessie8590","avatar":"https://community-static.tradeup.com/news/ae62e8ad7c913a19f3613c117b492985","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":11,"crmLevelSwitch":1,"authorIdStr":"3571194868777759","idStr":"3571194868777759"},"htmlText":"[強]&nbsp;","listText":"[強]&nbsp;","text":"[強]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/832329270","repostId":2161274943,"repostType":4,"repost":{"id":"2161274943","kind":"highlight","pubTimestamp":1629592848,"share":"https://ttm.financial/m/news/2161274943?lang=en_US&edition=fundamental","pubTime":"2021-08-22 08:40","market":"us","language":"zh","title":"Or on Monday! Pfizer vaccine to be fully approved in the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2161274943","media":"华尔街见闻","summary":"不仅能为更多的人提供保护，全面获批也可能是辉瑞疫苗的一大里程碑。\n据《纽约时报》援引消息人士的话报道称，美国食品和药物管理局(FDA)可能于周一全面批准辉瑞公司的新冠疫苗。\n随着文书工作和与辉瑞的谈判","content":"<p>Not only can it provide protection for more people, but full approval may also be<a href=\"https://laohu8.com/S/PFE\">Pfizer</a>A big milestone for vaccines.</p><p>According to<a href=\"https://laohu8.com/S/NYT\">The New York Times</a>The U.S. Food and Drug Administration (FDA) could fully approve Pfizer's COVID-19 vaccine on Monday, \"reported, citing sources.</p><p>The final review outcome could exceed that date as paperwork and negotiations with Pfizer continue, a move that would make Pfizer's vaccine the first COVID-19 vaccine to go from emergency use authorization to full FDA approval.</p><p>On Aug. 8, Dr. Anthony Fauci, the White House's chief medical adviser, told The Associated Press that he hopes the vaccine will be fully approved within August, which will make more companies and schools mandatory for people to get vaccinated.</p><p>With the surge of new crown cases across the United States in recent weeks, major U.S. companies have become increasingly stringent on vaccinating employees. Some companies say they will use full FDA approval as part of their decision-making process.</p><p>As of Friday, data from the Centers for Disease Control and Prevention (CDC) showed that<b>More than 203 million doses of Pfizer's vaccine have been administered nationwide, effectively protecting more than 91 million people in the United States.</b></p><p>Pfizer and BioNTech began applying for biopharmaceutical licenses for vaccines in May this year after receiving emergency use authorization from the FDA in December last year.</p><p>As previously reported by CNBC, drugmakers authorized by the European Union were banned from promoting their vaccines.</p><p>But if duly authorized,<b>Pfizer and BioNTech's vaccines will remain on the market after the epidemic is over, and they will be able to promote their vaccines directly to consumers.</b></p><p>On August 16, the two companies announced that after submitting clinical trial data to the FDA, they had begun the approval process to provide booster shots to fully vaccinated people.</p><p>Separately, senior health officials from agencies such as the CDC, the White House and the FDA said in a statement Wednesday that the effectiveness of mRNA vaccines will decline over time, especially for those with impaired immune systems.</p><p>They said that the United States will begin distributing the booster vaccine to the public in September.</p>","source":"wallstreetcn_api","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Or on Monday! Pfizer vaccine to be fully approved in the United States</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOr on Monday! Pfizer vaccine to be fully approved in the United States\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">华尔街见闻</strong><span class=\"h-time small\">2021-08-22 08:40</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Not only can it provide protection for more people, but full approval may also be<a href=\"https://laohu8.com/S/PFE\">Pfizer</a>A big milestone for vaccines.</p><p>According to<a href=\"https://laohu8.com/S/NYT\">The New York Times</a>The U.S. Food and Drug Administration (FDA) could fully approve Pfizer's COVID-19 vaccine on Monday, \"reported, citing sources.</p><p>The final review outcome could exceed that date as paperwork and negotiations with Pfizer continue, a move that would make Pfizer's vaccine the first COVID-19 vaccine to go from emergency use authorization to full FDA approval.</p><p>On Aug. 8, Dr. Anthony Fauci, the White House's chief medical adviser, told The Associated Press that he hopes the vaccine will be fully approved within August, which will make more companies and schools mandatory for people to get vaccinated.</p><p>With the surge of new crown cases across the United States in recent weeks, major U.S. companies have become increasingly stringent on vaccinating employees. Some companies say they will use full FDA approval as part of their decision-making process.</p><p>As of Friday, data from the Centers for Disease Control and Prevention (CDC) showed that<b>More than 203 million doses of Pfizer's vaccine have been administered nationwide, effectively protecting more than 91 million people in the United States.</b></p><p>Pfizer and BioNTech began applying for biopharmaceutical licenses for vaccines in May this year after receiving emergency use authorization from the FDA in December last year.</p><p>As previously reported by CNBC, drugmakers authorized by the European Union were banned from promoting their vaccines.</p><p>But if duly authorized,<b>Pfizer and BioNTech's vaccines will remain on the market after the epidemic is over, and they will be able to promote their vaccines directly to consumers.</b></p><p>On August 16, the two companies announced that after submitting clinical trial data to the FDA, they had begun the approval process to provide booster shots to fully vaccinated people.</p><p>Separately, senior health officials from agencies such as the CDC, the White House and the FDA said in a statement Wednesday that the effectiveness of mRNA vaccines will decline over time, especially for those with impaired immune systems.</p><p>They said that the United States will begin distributing the booster vaccine to the public in September.</p>\n<div class=\"bt-text\">\n\n\n<p> source：<a href=\"https://wallstreetcn.com/articles/3638520\">华尔街见闻</a></p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/6e474d690ea02c536f0fd4c03fc3ddef","relate_stocks":{},"source_url":"https://wallstreetcn.com/articles/3638520","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2161274943","content_text":"不仅能为更多的人提供保护，全面获批也可能是辉瑞疫苗的一大里程碑。\n据《纽约时报》援引消息人士的话报道称，美国食品和药物管理局(FDA)可能于周一全面批准辉瑞公司的新冠疫苗。\n随着文书工作和与辉瑞的谈判继续进行，最终审查结果可能会超过这一日期，此举将使辉瑞的疫苗成为首个从紧急使用授权到完全获得FDA批准的新冠疫苗。\n8月8日，白宫首席医疗顾问安东尼·福奇(Anthony Fauci)博士对美联社表示，他希望疫苗将在8月之内获得全面批准，这将使更多公司和学校强制要求人们接种疫苗。\n随着最近几周美国各地新冠病例的激增，美国各大公司对员工接种疫苗的相关规定也越来越严格。一些公司称，会将FDA的全面批准作为其决策过程的一部分。\n截至周五，美国疾病控制与预防中心（CDC）的数据显示，辉瑞的疫苗已经在全国范围内接种了超过2.03亿剂，使美国超过9100万人得到有效保护。\n辉瑞和BioNTech公司在去年12月获得FDA的紧急使用授权后，于今年5月开始申请疫苗的生物制药许可证。\n据CNBC此前报道，获得欧盟授权的制药商被禁止推广他们的疫苗。\n但如果获得正式授权，辉瑞和BioNTech的疫苗在疫情结束后仍将在市场上销售，而且能够直接向消费者宣传其疫苗。\n在8月16日，两家公司宣布，在向FDA提交临床试验数据后，他们开始了对完全接种者提供加强针的批准程序。\n另外，CDC、白宫和FDA等机构的高级卫生官员周三在一份声明中称，mRNA疫苗的有效性会随着时间的推移而下降，尤其是对那些免疫系统受损的人。\n他们表示，美国将于9月份开始向公众分发加强型的疫苗。","news_type":1,"symbols_score_info":{}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":31,"commentSize":3,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2161274943","isCrawlerRequest":true}